9 11, 2021 NTRK inhibitors, a successful example of a tissue-agnostic approach in anticancer targeted therapy Diatech Pharmacogenetics2021-11-09T17:01:50+01:00 Mehr erfahren
22 09, 2021 KRAS, a new weapon for the fight against lung cancer and more Diatech Pharmacogenetics2021-09-22T11:58:07+02:00 Mehr erfahren
31 05, 2021 Utility and use of NGS in clinical oncology: ESMO recommendations for patients with metastatic cancers Diatech Pharmacogenetics2021-05-31T15:56:48+02:00 Mehr erfahren
1 03, 2021 A breakthrough for the targeted therapy of RET+ tumours with new selective inhibitors Diatech Pharmacogenetics2021-03-01T15:25:16+01:00 Mehr erfahren
